R&D Universities and pharma companies need each other to create ... Academics and pharma executives seemingly live in very different worlds.
News UK team awarded grant for ‘second wave’ COVID-19 drug hunt A UK research group has been given £2.2 million in funding to seek out additional drugs to treat COVID-19, in case the first wave of therapies fail to show a benefit.
Partner Content Partner Content Review Microbiome Start-Up Success Stories & Business Models Your Invite - Microbiome Start-Up Focus Evening
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
